Further to intimation dated February 19, 2018 & March 14, 2018, Advanced Enzyme Technologies has informed that the Company has completed the acquisition of remaining 20% stake i.e. 50,000 equity shares of face value of MYR 1 each (Malaysia Ringgit) of Advanced Enzymes (Malaysia) Sdn. Bhd. (AEM), subsidiary. The said acquisition was made at face value for a total consideration of MYR 50,000 (equivalent to approximately Rs 867,800). In view of the above, AEM has become a wholly-owned subsidiary of the Company.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: